This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Davis, S. S., 1997, Biomedical applications of nanotechnology—implications for drug targeting and gene therapy. Trends Biotechnol. 15:217–224.
Chavany, C., Saison Behmoaras, T., Le Doan, T., Puisieux, F., Couvreur, P., and Helene, C., 1994, Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake. Pharm. Res. 11:1370–1378.
Bender, A. R., von Briesen, H., Kreuter, J., Duncan, I. B., and Rubsamen Waigmann, H., 1996, Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro. Antimicrob. Agents Chemother. 40:1467–1471.
Morin, C., Barratt, G., Fessi, H., Devissaguet, J. P., and Puisieux, F., 1993, Biodegradable nanocapsules containing a lipophilic immunomodulator: drug retention and tolerance towards macrophages in vitro. J. Drug Target. 1:157–164.
Labhasetwar, V., Song, C., and Levy, R. J., 1997, Nanoparticle drug delivery for restenosis. Adv. Drug Del. Rev. 24:63–85.
Labhasetwar, V., 1997, Nanoparticles for drug delivery. Pharmaceutical News 4:28–31.
Hedley, M. L., Curley, J., and Urban, R., 1998, Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 4:365–368.
Labhasetwar, V., and Dorle, A. K., 1990, Nanoparticles-a colloidal drug delivery system for primaquine and metronidazole. J. Control. Rel. 12:113–119.
O’Hagan, D. T., Palin, K. J., and Davis, S. S., 1989, Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization. Vaccine 7:213–216.
Desai, M. P., Labhasetwar, V., Amidon, G. L., and Levy, R. J., 1996, Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13:1838–1845.
Sakuma, S., Suzuki, N., Kikuchi, H., and Hiwatari, K., 1997, Oral peptide delivery using nanoparticles composed of novel copolymers having hydrophobic backbone and hydrophilic brances. Int. J. Pharmeutic. 149:93–106.
Damge, C., Vranckx, H., Balschmidt, P., and Couvreur, P., 1997, Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. J. Pharm. Sci. 86:1403–1409.
Thomas, N. W., Jenkins, P. G., Howard, K. A., Smith, M. W., Lavelle, E. C., Holland, J., and Davis, S. S., 1996, Particle uptake and translocation across epithelial membranes. J. Anat. 189:487–490.
De, S., Huai-yun, H., Miller, D. W., and Labhasetwar, V., 1998, Transferrin surface modification enhances transcytosis of nanospheres across Caco-2 cell monolayers. PharmSci. (Supplement) 1:S-58.
Ritschel, W. A., 1991, Targeting in the gastrointestinal tract: new approaches. Methods Find. Exp. Clin. Pharmacol. 13:313–336.
Naisbett, B., and Woodley, J., 1990, Binding of tomato lectin to the intestinal mucosa and its potential for oral drug delivery. Biochem. Soc. Trans. 18:879–880.
Kranz, D. M., Patrick, T. A., Brigle, K. E., Spinella, M. J., and Roy, E. J., 1995, Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis. Proc. Natl. Acad. Sci. U S A 92:9057–9061.
Cristiano, R. J., and Roth, J. A., 1995, Molecular conjugates: a targeted gene delivery vector for molecular medicine. J. Mol. Med. 73:479–486.
Lee, R. J., and Low, P. S., 1994, Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:3198–3204.
Dickler, H. B., and Collier, E., 1994, Gene therapy in the treatment of disease. J. Allergy Clin. Immunol. 94:942–951.
Afione, S. A., Conrad, C. K.., and Flotte, T. R., 1995, Gene therapy vectors as drug delivery systems. Clin. Pharmacokinet. 28:181–189.
Labhasetwar, V., 1998, Sustained-release gene delivery systems: principles and perspectives. In Self-Assebling Complexes for Gene Delivery (A. Kabanov, P. Felger, and L.W. Seymour eds), John Wiley & Sons, England, UK, pp. 387–399.
Labhasetwar, V., Bonadio, J., Goldstein, S. A., and Levy, R. J., 1999, Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. Colloids and Surfaces B: Biointerfaces 16:281–290.
Labhasetwar, V., Chen, B., Muller, D. W. M., Bonadio, J., Ciftci, K., March, K., and Levy, R. J., 1997, Gene-based therapies for restenosis. Adv. Drug Del. Rev. 24:109–120.
Roy, K., Mao, H. Q., Huang, S. K., and Leong, K. W., 1999, Oral gene delivery with chitosan—DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5:387–391.
Bonadio, J., Smiley, E., Patil, P., and Goldstein, S., 1999, Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5:753–759.
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., and Morrell, C., 1997, Biologically erodable microspheres as potential oral drug delivery systems. Nature 386: 410–414.
Shea, L. D., Smiley, E., Bonadio, J., and Mooney, D. J., 1999, DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17:551–554.
Labhasetwar, V., Bonadio, J., Goldstein, S., Chen, W., and Levy, R. J., 1998, A DNA controlled release coating for gene trasnfer: transfection in skeletal and cardiac muscles. J. Pharm. Sci. 87:1347–1350.
Desai, M., Hilfinger, J., Amidon, G., Levy, R. J., and Labhasetwar, V., 2000, Immune response with biodegradable nanospheres and alum: Studies in rabbits using staphylococcal entertoxin B-toxoid. J. Microencapsulation 17:215–225.
Cleland, J. L., Barron, L., Berman, P. W., Daugherty, A., Gregory, T., Lim, A., Vennari, J., Wrin, T., and Powell, M. F., 1996, Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response. J. Pharm. Sci. 85:1346–1349.
Aguado, M. T., 1993, Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems. Vaccine 11:596–597.
de Verdiere, A. C., Dubernet, C., Nemati, F., Soma, E., Appel, M., Ferte, J., Bernard, S., Puisieux, F., and Couvreur, P., 1997, Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br. J. Cancer 76: 198–205.
Hu, Y. P., Jarillon, S., Dubernet, C., Couvreur, P., and Robert, J., 1996, On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance. Cancer Chemother. Pharmacol. 37:556–560.
Couvreur, C., Roblot-Treupel, L., Poupon, M. F., Brasseur, F., and Puisieux, F., 1990, Nanoparticles as microcarriers for anticancer drugs. Adv. Drug Deliv. Rev. 5:209–230.
Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., and Fabbro, D., 1996, Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase [see comments]. Nat. Med. 2:668–675.
Schwab, G., Chavany, C., Duroux, I., Goubin, G., Lebeau, J., Helene, C., and Saison Behmoaras, T., 1994, Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proc. Natl. Acad. Sci. U S A 91:10460–10464.
Tondelli, L., Ricca, A., Laus, M., Lelli, M., and Citro, G., 1998, Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres. Nucleic Acids Res. 26:5425–5431.
Hashimoto, T., Wada, T., Fukuda, N., and Nagaoka, A., 1993, Effect of thyrotropin-releasing hormone on pentobarbitone-induced sleep in rats: continuous treatment with a sustained release injectable formulation. J. Pharm. Pharmacol. 45:94–97.
Ball, B. A., Wilker, C., Daels, P. F., and Burns, P. J., 1992, Use of progesterone in microspheres for maintenance of pregnancy in mares. Am. J. Vet. Res. 53:1294–1297.
Guzman, L. A., Labhasetwar, V., Song, C., Jang, Y., Lincoff, A. M., Levy, R., and Topol, E. J., 1996, Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation 94:1441–1448.
Labhasetwar, V., Song, C., Humphrey, W., Shebuski, R., and Levy, R. J., 1998, Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J. Pharm. Sci. 87: 1229–1234.
Humphrey, W. R., Erickson, L. A., Simmons, C. A., Northrup, J. L., Wishka, D. G., Morris, J., Labhasetwar, V., Song, C., Levy, R. J., and Shebuski, R. J., 1997, The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured coronary arteries. Adv. Drug Del. Rev. 24:87–108.
Fuster, V., Falk, E., Fallon, J. T., Badimon, L., Chesebro, J. H., and Badimon, J. J., 1995, The three processes leading to post PTCA restenosis: Dependence on the lesion substrate. Thrombosis and Haemostasis 74:552–559.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Davda, J., De, S., Zhou, W., Labhasetwar, V. (2002). Biodegradable Nanospheres: Therapeutic Applications. In: Chiellini, E., Sunamoto, J., Migliaresi, C., Ottenbrite, R.M., Cohn, D. (eds) Biomedical Polymers and Polymer Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/0-306-46842-5_2
Download citation
DOI: https://doi.org/10.1007/0-306-46842-5_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46472-0
Online ISBN: 978-0-306-46842-1
eBook Packages: Springer Book Archive